156 related articles for article (PubMed ID: 19085117)
1. Peptide-based delivery of steric-block PNA oligonucleotides.
Abes S; Ivanova GD; Abes R; Arzumanov AA; Williams D; Owen D; Lebleu B; Gait MJ
Methods Mol Biol; 2009; 480():85-99. PubMed ID: 19085117
[TBL] [Abstract][Full Text] [Related]
2. Splice redirection as a convenient assay to monitor CPP-ON efficiency and mechanism.
Abes R; Arzumanov AA; Saleh AF; Said Hassane F; Gait MJ; Lebleu B
Methods Mol Biol; 2011; 683():307-20. PubMed ID: 21053139
[TBL] [Abstract][Full Text] [Related]
3. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
[TBL] [Abstract][Full Text] [Related]
4. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
[TBL] [Abstract][Full Text] [Related]
5. Cell penetrating peptide conjugates of steric block oligonucleotides.
Lebleu B; Moulton HM; Abes R; Ivanova GD; Abes S; Stein DA; Iversen PL; Arzumanov AA; Gait MJ
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):517-29. PubMed ID: 18037527
[TBL] [Abstract][Full Text] [Related]
6. Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.
Resina S; Abes S; Turner JJ; Prevot P; Travo A; Clair P; Gait MJ; Thierry AR; Lebleu B
Int J Pharm; 2007 Nov; 344(1-2):96-102. PubMed ID: 17600642
[TBL] [Abstract][Full Text] [Related]
7. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
8. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
Kilk K; Langel U
Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
[TBL] [Abstract][Full Text] [Related]
9. Noncovalent peptide-mediated delivery of chemically modified steric block oligonucleotides promotes splice correction: quantitative analysis of uptake and biological effect.
Laufer SD; Recke AL; Veldhoen S; Trampe A; Restle T
Oligonucleotides; 2009 Mar; 19(1):63-80. PubMed ID: 19196099
[TBL] [Abstract][Full Text] [Related]
10. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
[TBL] [Abstract][Full Text] [Related]
11. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
[TBL] [Abstract][Full Text] [Related]
12. Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides.
Abes R; Arzumanov A; Moulton H; Abes S; Ivanova G; Gait MJ; Iversen P; Lebleu B
J Pept Sci; 2008 Apr; 14(4):455-60. PubMed ID: 18236382
[TBL] [Abstract][Full Text] [Related]
13. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.
El Andaloussi S; Said Hassane F; Boisguerin P; Sillard R; Langel U; Lebleu B
Methods Mol Biol; 2011; 764():75-89. PubMed ID: 21748634
[TBL] [Abstract][Full Text] [Related]
15. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
17. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates.
Kaihatsu K; Huffman KE; Corey DR
Biochemistry; 2004 Nov; 43(45):14340-7. PubMed ID: 15533038
[TBL] [Abstract][Full Text] [Related]
18. Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption.
Shiraishi T; Nielsen PE
Nat Protoc; 2006; 1(2):633-6. PubMed ID: 17406290
[TBL] [Abstract][Full Text] [Related]
19. Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide.
Abes S; Turner JJ; Ivanova GD; Owen D; Williams D; Arzumanov A; Clair P; Gait MJ; Lebleu B
Nucleic Acids Res; 2007; 35(13):4495-502. PubMed ID: 17584792
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
Wolf Y; Pritz S; Abes S; Bienert M; Lebleu B; Oehlke J
Biochemistry; 2006 Dec; 45(50):14944-54. PubMed ID: 17154532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]